ATE132186T1 - Verfahren zur inaktivierung von viren - Google Patents

Verfahren zur inaktivierung von viren

Info

Publication number
ATE132186T1
ATE132186T1 AT92908672T AT92908672T ATE132186T1 AT E132186 T1 ATE132186 T1 AT E132186T1 AT 92908672 T AT92908672 T AT 92908672T AT 92908672 T AT92908672 T AT 92908672T AT E132186 T1 ATE132186 T1 AT E132186T1
Authority
AT
Austria
Prior art keywords
liposaccharide
solution
viruses
inactivation
protein
Prior art date
Application number
AT92908672T
Other languages
English (en)
Inventor
Roland Schmitthaeusler
Wisdom Klagba
Goffic Francois Le
Original Assignee
Vegatec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vegatec filed Critical Vegatec
Application granted granted Critical
Publication of ATE132186T1 publication Critical patent/ATE132186T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16661—Methods of inactivation or attenuation
    • C12N2710/16663—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92908672T 1991-03-29 1992-03-27 Verfahren zur inaktivierung von viren ATE132186T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR919103892A FR2674536B1 (fr) 1991-03-29 1991-03-29 Procede d'inactivation de virus et composition pharmaceutique pour l'inactivation de virus.

Publications (1)

Publication Number Publication Date
ATE132186T1 true ATE132186T1 (de) 1996-01-15

Family

ID=9411308

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92908672T ATE132186T1 (de) 1991-03-29 1992-03-27 Verfahren zur inaktivierung von viren

Country Status (7)

Country Link
EP (1) EP0578726B1 (de)
JP (1) JPH06511383A (de)
AT (1) ATE132186T1 (de)
CA (1) CA2107092A1 (de)
DE (1) DE69207181D1 (de)
FR (1) FR2674536B1 (de)
WO (1) WO1992017570A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19528221C2 (de) * 1995-08-01 1998-10-22 Blutspendedienst Der Drk Lande Verfahren zur Herstellung eines virussicheren, therapeutischen Präparates aus Humanplasma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2475572A1 (fr) * 1980-02-11 1981-08-14 Pasteur Institut Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications
AT385203B (de) * 1985-04-26 1988-03-10 Immuno Ag Verfahren zur herstellung einer fruehsommermeningoenzephalitis-virus (fsme-virus)-vakzine

Also Published As

Publication number Publication date
CA2107092A1 (fr) 1992-09-30
DE69207181D1 (de) 1996-02-08
JPH06511383A (ja) 1994-12-22
WO1992017570A1 (fr) 1992-10-15
FR2674536A1 (fr) 1992-10-02
EP0578726B1 (de) 1995-12-27
FR2674536B1 (fr) 1994-10-21
EP0578726A1 (de) 1994-01-19

Similar Documents

Publication Publication Date Title
FI883739A0 (fi) Menetelmä terapeuttisesti aktiivisten fenoksi-indaanimetyyliamiinijohdannaisten valmistamiseksi
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
GR3034279T3 (en) Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
DE68914488T2 (de) 2-(2-Hydroxy-3-phenoxypropylamino)ethylphenoxyacetamide, Verfahren und Zwischenprodukte zu deren Herstellung.
GEP20012413B (en) Novel Substituted Cyclic Amino Acids as Pharmaceutical Agents
DE69830751D1 (de) Polyaromatische Verbindungen zur Behandlung von Herpes-Infektionen
DE69019533D1 (de) Behandlung von hiv-infizierungen und nützliche verbindungen dafür.
DE69129115T2 (de) Neues verfahren zur behandlung von depression
ATE161013T1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
DE69214610T2 (de) Verfahren zur Behandlung von Erdgas
ATE81510T1 (de) Loeslichkeits-, reinigungs- und charakterisierungsverfahren fuer proteine aus unloeslichen proteinaggregaten oder proteinkomplexen und diesbezuegliche praeparate.
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
ATE70067T1 (de) Peptidaminoalkoholderivate, welche ein tetrasubstituiertes kohlenstoffatom besitzen, hemmungsstoffe von renin und proteasesaeuren, verfahren zur herstellung und pharmazeutische zusammensetzungen.
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DK482185A (da) Peptider, deres fremstilling og anvendelse som laegemidler
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
DE69104220T2 (de) Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten.
DE3885818D1 (de) Trinatriumsalz des 2,4,6-Trimercapto-s-triazin-nonahydrats und Verfahren zur Herstellung.
ATE132186T1 (de) Verfahren zur inaktivierung von viren
DE69122960D1 (de) Verfahren und zubereitungen für die behandlung von verletzungen
ATE96805T1 (de) Verfahren zur rueckgewinnung rekombinanter proteine.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
ATE114468T1 (de) Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs.
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
DE3874606D1 (de) Behandlung von viraler infektion.